Dataset from A Phase 1 Open-label Study of the Safety, Tolerability, and Pharmacokinetics of d- and l-Amphetamine After Multiple Daily Doses of SHP465 6.25 mg Administered in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder

The purpose of this study is to evaluate the pharmacokinetics (PK), safety, and tolerability of SHP465 in children aged 4 to 5 years with ADHD after multiple daily doses of 6.25 milligram (mg) SHP465

本研究旨在评估4至5岁注意缺陷多动障碍（Attention Deficit Hyperactivity Disorder, ADHD）儿童接受每日多次6.25毫克（mg）SHP465给药后的药代动力学（pharmacokinetics, PK）、安全性及耐受性。